Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Related Articles by Review for PubMed (Select 23204254)

1.

Chronic bronchitis and chronic obstructive pulmonary disease.

Kim V, Criner GJ.

Am J Respir Crit Care Med. 2013 Feb 1;187(3):228-37. doi: 10.1164/rccm.201210-1843CI. Epub 2012 Nov 29. Review.

PMID:
23204254
2.

Clinical issues of mucus accumulation in COPD.

Ramos FL, Krahnke JS, Kim V.

Int J Chron Obstruct Pulmon Dis. 2014 Jan 24;9:139-50. doi: 10.2147/COPD.S38938. eCollection 2014. Review.

3.

Exacerbations of chronic obstructive pulmonary disease.

Wedzicha JA, Donaldson GC.

Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Review.

4.

Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.

Maestrelli P, Saetta M, Mapp CE, Fabbri LM.

Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S76-80. Review.

PMID:
11734472
5.

[Contemporary therapy of chronic obstructive pulmonary disease and its new directions].

Vermel' AE.

Klin Med (Mosk). 2007;85(1):8-15. Review. Russian.

PMID:
17419348
6.

The rationale for pharmacologic therapy in stable chronic obstructive pulmonary disease.

Campos MA, Wanner A.

Am J Med Sci. 2005 Apr;329(4):181-9. Review.

PMID:
15832101
7.

Pharmacological treatment of chronic obstructive pulmonary disease.

Montuschi P.

Int J Chron Obstruct Pulmon Dis. 2006;1(4):409-23. Review.

8.

New treatment strategies for COPD. Pairing the new with the tried and true.

Cote CG, Celli BR.

Postgrad Med. 2005 Mar;117(3):27-34. Review.

PMID:
15782671
9.

COPD: current therapeutic interventions and future approaches.

Barnes PJ, Stockley RA.

Eur Respir J. 2005 Jun;25(6):1084-106. Review.

10.
11.

Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality.

Pelkonen M.

Curr Opin Pulm Med. 2008 Mar;14(2):105-9. doi: 10.1097/MCP.0b013e3282f379e9. Review.

PMID:
18303418
12.

[Treatment of distal airways involvement in COPD].

Devillier P, Jebrak G, Morel H, Chinet T, Didier A, Roche N.

Rev Mal Respir. 2011 Dec;28(10):1340-56. doi: 10.1016/j.rmr.2011.08.005. Epub 2011 Nov 6. Review. French.

PMID:
22152941
13.

Treatment of airway mucus hypersecretion.

Rogers DF, Barnes PJ.

Ann Med. 2006;38(2):116-25. Review.

PMID:
16581697
14.

Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Forey BA, Thornton AJ, Lee PN.

BMC Pulm Med. 2011 Jun 14;11:36. doi: 10.1186/1471-2466-11-36. Review.

15.

Mucoactive drugs in the management of chronic obstructive pulmonary disease.

Del Donno M, Olivieri D.

Monaldi Arch Chest Dis. 1998 Dec;53(6):714-9. Review.

PMID:
10063352
16.

Future directions in the pharmacologic therapy of chronic obstructive pulmonary disease.

Buhl R, Farmer SG.

Proc Am Thorac Soc. 2005;2(1):83-93. Review.

PMID:
16113474
17.
18.

Disease of the airways in chronic obstructive pulmonary disease.

Cosio Piqueras MG, Cosio MG.

Eur Respir J Suppl. 2001 Dec;34:41s-49s. Review.

19.

[Pharmacological treatment of COPD and future of anti-inflammatory therapy].

Watz H, Bitter-Suermann S, Kanniess F, Magnussen H.

Med Klin (Munich). 2006 Apr 15;101(4):283-92. Review. German.

PMID:
16607484
20.

Mucus hypersecretion in chronic obstructive pulmonary disease.

Rogers DF.

Novartis Found Symp. 2001;234:65-77; discussion 77-83. Review.

PMID:
11199104
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk